A novel component of the metabolic syndrome: The oxidative stress

Nutrition, Metabolism and Cardiovascular Diseases

Volumn 20, Issue 1, 2010, Pages 72-77

  Hopps, E ^a   Noto, D ^a   Caimi, G ^a   Averna, M R ^a  

^a UNIVERSITY OF PALERMO   (Italy)

Author keywords

Cardiovascular risk; Metabolic syndrome; Oxidative stress

Indexed keywords

ABDOMINAL OBESITY; ANIMAL; CARDIOVASCULAR DISEASE; DYSLIPIDEMIA; HUMAN; HYPERTENSION; INFLAMMATION; METABOLIC SYNDROME X; NON INSULIN DEPENDENT DIABETES MELLITUS; OXIDATIVE STRESS; PATHOPHYSIOLOGY; REVIEW; RISK FACTOR;

ANIMALS; CARDIOVASCULAR DISEASES; DIABETES MELLITUS, TYPE 2; DYSLIPIDEMIAS; HUMANS; HYPERTENSION; INFLAMMATION; METABOLIC SYNDROME X; OBESITY, ABDOMINAL; OXIDATIVE STRESS; RISK FACTORS;

EID: 72649106550     PISSN: 09394753     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.numecd.2009.06.002     Document Type: Review

References (50)

1. Guerrero-Romero F., and Rodriguez-Moràn M. Hypomagnesemia, oxidative stress, inflammation and metabolic syndrome. Diabetes Metab Res Rev 22 (2006) 471-476
2. Demircan N., Gurel A., Armuctu F., Unalacak M., Aktunç, and Atmaca H. The evaluation of serum cystatin C, malonildialdehyde and total antioxidant status in patients with metabolic syndrome. Med Sci Monit 14 (2008) 97-101
3. Barbato J.E., Zuckerbraun B.S., Overhaus M., Raman K.G., and Tzeng E. Nitric oxide modulates vascular inflammation and intimal hyperplasia in insulin resistance and the metabolic syndrome. Am J Physiol Heart Circ Physiol 289 (2005) 228-236
4. Sun Y.X., Hu S.J., Zhang X.H., Sun J., Zhu C.H., and Zhang Z.J. Plasma levels of vWF and NO in patients with metabolic syndrome and their relationship with metabolic disorders. Zhejiang Da Xue Xue Bao Yi Xue Ban 35 (2006) 315-318
5. Meaney E., Vela A., Samaniego V., Meaney A., Asbun J., Zempoalteca J.C., et al. Metformin, arterial function, intima-media thickness and nitroxidation in metabolic syndrome: the Mefisto Study. Clin Exp Pharmacol Physiol 35 (2008) 895-903
6. Dalle-Donne I., Aldini G., Carini M., Colombo R., Rossi R., and Milzani A. Protein carbonylation, cellular dysfunction and disease progression. J Cell Mol Med 2 (2006) 389-406
7. Sayre L.M., Lin D., Yuan Q., Zhu X., and Tang X. Protein adducts generated from products of lipid oxidation: focus on HNE and ONE. Drug Metab Rev 38 (2006) 651-675
8. Aldini G., Dalle-Donne I., Facino R.M., Milzani A., and Carini M. Intervention strategies to inhibit protein carbonylation by lipoxidation-derived reactive carbonyls. Med Res Rev 27 (2007) 817-868
9. Ford E.S., Mokdad A.H., Giles W.H., and Brown D.W. The metabolic syndrome and antioxidant concentrations. Diabetes 52 (2003) 2346-2352
10. Demirbag R., Yilmaz R., Gur M., Celik H., Guzel S., Selek S., et al. DNA damage in metabolic syndrome and its association with antioxidative and oxidative measurements. Int J Clin Pract 60 (2006) 1187-1193
11. Andreeva-Gateva P., Popova D., and Orbetsova V. Antioxidant parameters in metabolic syndrome - a dynamic evaluation during oral glucose tolerance test. Vutr Boles 33 (2001) 48-53
12. Belia S., Santilli F., Beccafico S., De Feudis L., Morabito C., Davi G., et al. Oxidative-induced membrane damage in diabetes lymphocytes: effects on intracellular Ca(2+) homeostasis. Free Radic Res 43 2 (2009 Feb) 138-148
13. Davì G., Ciabattoni G., Consoli A., Mezzetti A., Falco A., Santarone S., et al. In vivo formation of 8-iso-prostaglandin f2alpha and platelet activation in diabetes mellitus: effects of improved metabolic control and vitamin E supplementation. Circulation 99 2 (1999 Jan 19) 224-229
14. Chander P.N., Gealekman O., Brodsky S.V., Elitok S., Tojo A., Crabtree M., et al. Nephropathy in Zucker diabetic fat rat is associated with oxidative and nitrosative stress: prevention by chronic therapy with a peroxynitrite scavenger Ebselen. J Am Soc Nephrol 15 (2004) 2391-2403
15. Namikoshi T., Tomita N., Satoh M., Haruna Y., Kobayashi S., Komai N., et al. Olmesartan ameliorates renovascular injury and oxidative stress in Zucker obese rats enhanced by dietary protein. Am J Hypertens 20 (2007) 1085-1091
16. Abdilla N., Tormo M.C., Fabia M.J., Chaves F.J., Saez G., and Redon J. Impact of the components of metabolic syndrome on oxidative stress and enzymatic antioxidant activity in essential hypertension. J Hum Hypertens 21 (2007) 68-75
17. Kagota S., Tada Y., Kubota Y., Nejime N., Yamaguchi Y., Nakamura K., et al. Peroxynitrite is involved in the dysfunction of vasorelaxation in SHR/NDmcr-cp rats, spontaneously hypertensive obese rats. J Cardiovasc Pharmacol 50 (2007) 677-685
18. Kunitomo M., Yamaguchi Y., Kagota S., and Otsubo K. Beneficial effect of Coenzyme Q10 on increased oxidative and nitrative stress and inflammation and individual metabolic components developing in a rat model of metabolic syndrome. J Pharmacol Sci 107 (2007) 128-137
19. Roberts C.K., Barnard R.J., Sindhu R.K., Jurczak M., Ehdaie A., and Vaziri N.D. Oxidative stress and dysregulation of NADP(H) oxidase and antioxidant enzymes in diet-induced metabolic syndrome. Metabolism 55 (2006) 928-934
20. Leighton F., Miranda-Rottmann S., and Urqiaga I. A central role of eNOS in the protective effect of wine against metabolic syndrome. Cell Biochem Funct 24 (2006) 291-298
21. Gonzàlez-Sànchez J., Martìnez-Larrad M.T., Sàez M.E., Zabena C., Martìnez-Calatrava M.J., and Serrano-Rìos M. Endothelial nitric oxide synthase haplotypes are associated with features of metabolic syndrome. Clin Chem 53 (2007) 91-97
22. Kielstein J.T., and Tsao P.S. From Zanius to ADMA: ADMA a new "adipocytokine" and its potential role in metabolic syndrome. J Nephrol 20 (2007) 515-517
23. Galili O., Versari D., Sattler K.J., Olson M.L., Mannheim D., McConnel J.P., et al. Early experimental obesity is associated with coronary endhotelial dysfunction and oxidative stress. Am J Physiol Heart Circ Physiol 292 (2007) 904-911
24. Devaraj S., Wang-Polagruto J., Polagruto J., Keen C.L., and Jialal I. High-fat, energy-dense, fast-food-style breakfast results in an increase in oxidative stress in metabolic syndrome. Metabolism 57 (2008) 867-870
25. Azadbakht L., Kimiagar M., Mehrabi Y., Esmaillzadeh A., Hu F.B., and Willett W.C. Dietary soya intake alters plasma antioxidant status and lipid peroxidation in postmenopausal women with the metabolic syndrome. Br J Nutr 98 (2007) 807-813
26. Cardona F., Tùnez I., Tasset I., Montilla P., Collantes E., and Tinahones F.J. Fat overload aggravates oxidative stress in patients with the metabolic syndrome. Eur J Clin Invest 38 (2008) 510-515
27. Krzystek-Korpacka M., Patryn E., Boehm D., Berdowska I., Zielinski B., and Noczynska A. Advanced oxidation protein products (AOPPs) in juvenile overweight and obesity prior to and following weight reduction. Clin Biochem 41 (2008) 943-949
28. Sebeková K., Boor P., Valachovicová M., Blazícek P., Parrák V., Babinská K., et al. Association of metabolic syndrome risk factors with selected markers of oxidative status and microinflammation in healthy omnivores and vegetarians. Mol Nutr Food Res 50 (2006) 858-868
29. Palmieri V.O., Grattagliano I., Portincasa P., and Palasciano G. Systemic oxidative alterations are associated with visceral adiposity and liver steatosis in patients with metabolic syndrome. J Nutr 136 (2006) 3022-3026
30. Molnàr D., Decsi T., and Koletzko B. Reduced antioxidant status in obese children with multimetabolic syndrome. Int J Obes Relat Metab Disord 28 (2004) 1197-1202
31. Fujita K., Nishizawa H., Funahashi T., Shimomura I., and Shimabukuro M. Systemic oxidative stress is associated with visceral fat accumulation and the metabolic syndrome. Circ J 70 (2006) 1437-1442
32. Furukawa S., Fujita K., Shimabukuro M., Iwaki M., Yamada Y., Nakajima Y., et al. Increased oxidative stress in obesity and its impact on metabolic syndrome. J Clin Invest 114 (2004) 1752-1761
33. Tesauro M., Schinzari F., Iantorno M., Rizza S., Melina D., Lauro D., et al. Ghrelin improves endothelial function in patients with metabolic syndrome. Circulation 112 (2005) 2986-2992
34. Xu X., Jhun B.S., Ha C.H., and Jin Z.J. Molecular mechanisms of ghrelin-mediated endothelial nitric oxide synthase activation. Endocrinology 149 (2008) 4183-4192
35. Dunajska K., Lwow F., Tworowska U., Jedrzejuk D., and Milewicz A. Relationship of beta(3)-adrenergic receptor polymorphism with metabolic syndrome and oxidative stress parameters in postmenopausal women. Endokrynol Pol 58 (2007) 201-206
36. Maeda K., Yasunari K., Sato E.F., and Inoue M. Enhanced oxidative stress in neutrophils from hyperlipidemic guinea pig. Atherosclerosis 181 (2005) 87-92
37. Umeji K., Umemoto S., Itoh S., Tanaka M., Kawahara S., Fukai T., et al. Comparative effects of pitavastatin and probucol on oxidative stress, Cu/Zn superoxide dismutase, PPAR-γ and aortic stiffness in hypercolesterolemia. Am J Physiol Circ Physiol 291 (2006) 2522-2532
38. Li R., Wang W.Q., Zhang H., Fan Q., Cristopher T.A., Lopez B.L., et al. Adiponectin improves endothelial function in hyperlipidemic rats by reducing oxidative/nitrative stress and differential regulation of eNOS/iNOS activity. Am J Physiol Endocrinol Metab 293 (2007) 1703-1708
39. Saiki R., Okazaki M., Iwai S., Kumai T., Kobayashi S., and Oguchi K. Effects of pioglitazone on increases in visceral fat accumulation and oxidative stress in spontaneously hypertensive hyperlipidemic rats fed a high-fat diet and sucrose solution. J Pharmacol Sci 105 (2007) 157-167
40. Cardona F., Tunez I., Tasset I., Murri M., and Tinahones F.J. Similar increase in oxidative stress after fat overload in persons with baseline hypertriglyceridemia with or without the metabolic syndrome. Clin Biochem 41 (2008) 701-705
41. Martinez-Hervas S., Fandos M., Real J.T., Espinosa O., Chaves F.J., Saez G.T., et al. Insulin resistance and oxidative stress in familial combined hyperlipidemia. Atherosclerosis 199 (2008) 384-389
42. Ferri J., Martinez-Hervas S., Espinosa O., Fandos M., Pedro T., Real J.T., et al. 8-oxo-dihydro-2′-deoxyguanosine as a marker of DNA oxidative stress in individuals with combined familiar hyperlipidemia. Med Clin (Barc) 7 (2008) 1-4
43. Araujo F.B., Barbosa D.S., Hsin C.Y., Maranhao R.C., and Abdalla D.S. Evaluation of oxidative stress in patients with hyperlipidemia. Atherosclerosis 117 (1995) 61-71
44. Mazor R., Shurtz-Swirski R., Farah R., Kristal B., Shapiro G., Dorlechter F., et al. Primed polymorphonuclear leukocytes constitute a possible link between inflammation and oxidative stress in hyperlipidemic patients. Atherosclerosis 197 (2008) 937-943
45. Skalicky J., Muzakova V., Kandar R., Meloun M., Rousar T., and Palicka V. Evaluation of oxidative stress and inflammation in obese adults with metabolic syndrome. Clin Chem Lab Med 46 (2008) 499-505
46. Van Guilder G.P., Hoetzer G.L., Greiner J.J., Stauffer B.L., and Desouza C.A. Influence of metabolic syndrome on biomarkers of oxidative stress and inflammation in obese adults. Obesity 14 (2006) 2127-2131
47. Girona J., Manzanares J.M., Marimón F., Cabré A., Heras M., Guardiola M., et al. Oxidized to non-oxidized lipoprotein ratios are associated with arteriosclerosis and the metabolic syndrome in diabetic patients. Nutr Metab Cardiovasc Dis 18 (2007) 380-387
48. Chen J., Park H.C., Patschan S., Brodsky S.V., Gealikman O., Kuo M.C., et al. Premature vasculature senescence in metabolic syndrome: could it be prevented and reversed by a selenorganic antioxidant and peroxinitrite scavenger Ebselen?. Drug Discov Today Ther Strateg 4 (2007) 93-99
49. Sautin Y.Y., Nakagawa T., Zharikov S., and Johnson R.J. Adverse effects of the classic antioxidant uric acid in adipocytes: NADPH oxidase-mediated oxidative/nitrosative stress. Am J Physiol Cell Physiol 293 (2007) 584-596
50. Yiginer O., Ozcelik F., Inanc T., Aparci M., Ozmen N., Cingozbay B.Y., et al. Allopurinol improves endothelial function and reduces oxidant-inflammatory enzyme of myeloperoxidase in metabolic syndrome. Clin Res Cardiol 97 (2008) 334-340